FIVE STAR SENIOR LIVING INC (FVE) Stock Fundamental Analysis

NASDAQ:FVE • US33832D1063

2.94
+0.07 (+2.44%)
Last: Jan 27, 2022, 08:26 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

FVE gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. FVE may be in some trouble as it scores bad on both profitability and health. FVE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • FVE had negative earnings in the past year.
FVE Yearly Net Income VS EBIT VS OCF VS FCFFVE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 0 50M -50M -100M

1.2 Ratios

Industry RankSector Rank
ROA -4.4%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FVE Yearly ROA, ROE, ROICFVE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 0 -20 -40 -60 -80 -100

1.3 Margins

Industry RankSector Rank
OM 0.52%
PM (TTM) -1.57%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FVE Yearly Profit, Operating, Gross MarginsFVE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • The number of shares outstanding for FVE has been increased compared to 1 year ago.
  • Compared to 1 year ago, FVE has a worse debt to assets ratio.
FVE Yearly Shares OutstandingFVE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 10M 20M 30M
FVE Yearly Total Debt VS Total AssetsFVE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 100M 200M 300M 400M 500M

2.2 Solvency

  • FVE has an Altman-Z score of 2.16. This is not the best score and indicates that FVE is in the grey zone with still only limited risk for bankruptcy at the moment.
  • A Debt/Equity ratio of 0.05 indicates that FVE is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 2.16
ROIC/WACCN/A
WACCN/A
FVE Yearly LT Debt VS Equity VS FCFFVE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 0 100M -100M 200M

2.3 Liquidity

  • FVE has a Current Ratio of 1.51. This is a normal value and indicates that FVE is financially healthy and should not expect problems in meeting its short term obligations.
  • A Quick Ratio of 1.51 indicates that FVE should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 1.51
FVE Yearly Current Assets VS Current LiabilitesFVE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The earnings per share for FVE have decreased strongly by -117.90% in the last year.
  • Looking at the last year, FVE shows a very negative growth in Revenue. The Revenue has decreased by -15.26% in the last year.
  • Measured over the past years, FVE shows a decrease in Revenue. The Revenue has been decreasing by -3.15% on average per year.
EPS 1Y (TTM)-117.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-283.33%
Revenue 1Y (TTM)-15.26%
Revenue growth 3Y-5.89%
Revenue growth 5Y-3.15%
Sales Q2Q%-23.52%

3.2 Future

  • Based on estimates for the next years, FVE will show a very strong growth in Earnings Per Share. The EPS will grow by 61.66% on average per year.
  • FVE is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -9.86% yearly.
EPS Next Y-120%
EPS Next 2Y28.06%
EPS Next 3Y53.83%
EPS Next 5Y61.66%
Revenue Next Year-19.45%
Revenue Next 2Y-18%
Revenue Next 3Y-11.55%
Revenue Next 5Y-9.86%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
FVE Yearly Revenue VS EstimatesFVE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B
FVE Yearly EPS VS EstimatesFVE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2020 2021 2022 2023 2024 2025 0 2 -2 -4

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for FVE. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for FVE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FVE Price Earnings VS Forward Price EarningsFVE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.27
FVE Per share dataFVE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • FVE's earnings are expected to grow with 53.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.06%
EPS Next 3Y53.83%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for FVE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

FIVE STAR SENIOR LIVING INC

NASDAQ:FVE (1/27/2022, 8:26:29 PM)

2.94

+0.07 (+2.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A
Earnings (Next)02-23
Inst Owners0%
Inst Owner Change0%
Ins Owners0.72%
Ins Owner Change0%
Market Cap93.36M
Revenue(TTM)1.04B
Net Income(TTM)-16.30M
Analysts80
Price Target6.63 (125.51%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.09
P/FCF N/A
P/OCF N/A
P/B 0.49
P/tB N/A
EV/EBITDA 0.27
EPS(TTM)-0.48
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS32.74
BVpS6.04
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.4%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 0.52%
PM (TTM) -1.57%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover2.81
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 1.51
Altman-Z 2.16
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-117.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-283.33%
EPS Next Y-120%
EPS Next 2Y28.06%
EPS Next 3Y53.83%
EPS Next 5Y61.66%
Revenue 1Y (TTM)-15.26%
Revenue growth 3Y-5.89%
Revenue growth 5Y-3.15%
Sales Q2Q%-23.52%
Revenue Next Year-19.45%
Revenue Next 2Y-18%
Revenue Next 3Y-11.55%
Revenue Next 5Y-9.86%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

FIVE STAR SENIOR LIVING INC / FVE FAQ

Can you provide the ChartMill fundamental rating for FIVE STAR SENIOR LIVING INC?

ChartMill assigns a fundamental rating of 3 / 10 to FVE.


What is the valuation status for FVE stock?

ChartMill assigns a valuation rating of 3 / 10 to FIVE STAR SENIOR LIVING INC (FVE). This can be considered as Overvalued.


What is the profitability of FVE stock?

FIVE STAR SENIOR LIVING INC (FVE) has a profitability rating of 1 / 10.


What is the financial health of FIVE STAR SENIOR LIVING INC (FVE) stock?

The financial health rating of FIVE STAR SENIOR LIVING INC (FVE) is 5 / 10.


Can you provide the expected EPS growth for FVE stock?

The Earnings per Share (EPS) of FIVE STAR SENIOR LIVING INC (FVE) is expected to decline by -120% in the next year.